<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="81597">
  <stage>Registered</stage>
  <submitdate>18/10/2006</submitdate>
  <approvaldate>20/10/2006</approvaldate>
  <actrnumber>ACTRN12606000453583</actrnumber>
  <trial_identification>
    <studytitle>Lipid lowering potential of combined phytosterols and long chain omega-3 fatty acids</studytitle>
    <scientifictitle>Phytosterols and omega-3 fatty acids for alleviation of plasma lipids in participants with Hyperlipidaemia</scientifictitle>
    <utrn />
    <trialacronym>POFA Trial</trialacronym>
    <secondaryid>nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Hyperlipidaemia</healthcondition>
    <conditioncode>
      <conditioncode1>Blood</conditioncode1>
      <conditioncode2>Other blood disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Participants are randomised to recieve either 4g omega-3 fish oil capsules or 25g plant sterol spread + 4g fish oil capsules for 3 weeks for the treatment. Participants are assessed at baseline and again at the completion of the study (3 weeks)</interventions>
    <comparator>4g sunola oil capsules or 25g plant sterol spread + 4g sunola oil capsules for 3 weeks for the control. </comparator>
    <control>Active</control>
    <interventioncode>Lifestyle</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The primary outcome of this trial is to evaluate the effect of phytosterols and omega-3 fatty acids on plasma cholesterol and triglyceride levels.</outcome>
      <timepoint>Blood samples will be taken at the commencement of the study and again at the completion of the study (3 weeks).  A full blood lipid pannel including cholesterol, triglycerides, LDL and HDL will be generated from each sample.  Baseline samples will be comparred with post intervention samples to determine the effect of phytosterols and omega-3 fatty acids on plasma cholesterol and triglycerides.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>The secondary outcomes are to evaluate changes in weight, blood pressure and markers of inflammation.</outcome>
      <timepoint>All these outcomes are measured at baseline and again at the completion of the study (3 weeks).</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Participants with hyperlipidemia, and are not taking any lipid-lowering medications.</inclusivecriteria>
    <inclusiveminage>35</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Subjects already taking fish oil supplements and/or regularly consuming phytosterol enriched fat spreads.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Numbered containers</concealment>
    <sequence>Random order generation via block randomisation using a randomisation table from a statistics book</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>30/10/2006</anticipatedstartdate>
    <actualstartdate>14/02/2007</actualstartdate>
    <anticipatedenddate />
    <actualenddate>28/11/2008</actualenddate>
    <samplesize>60</samplesize>
    <actualsamplesize>60</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>The University of Newcastle</primarysponsorname>
    <primarysponsoraddress>University of Newcastle
University Drive
Callaghan, NSW 2308</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Other</fundingtype>
      <fundingname>Pilot Research Grant</fundingname>
      <fundingaddress>University of Newcastle
University Drive
Callaghan, NSW 2308</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>N/A</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>No change required, the details have already been provided.</summary>
    <trialwebsite />
    <publication>M.A. Micallef and M.L. Garg (2008) The lipid-lowering effects of phytosterols and (n-3) polyunsaturated fatty acids are synergistic and complementary in hyperlipidemic men and women. Journal of Nutrition 138, 1086-1090.

M.A. Micallef and M.L. Garg (2009) Anti-inflammatory and cardio-protective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals. Atherosclerosis 204, 476-482.

M.A. Micallef and M.L. Garg (2007) Synergistic lipid-lowering effects of phytosterols and long chain omega-3 fatty acids (LCn-3PUFA) in hyperlipidemic subjects. Australian Atherosclerosis Society Meeting, Fremantle, WA, Australia.

Micallef, M.A &amp; Garg, M.L. (2008) Anti-inflammatory and cardio-protective effects of omega-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals. Asia Pacific Journal of Clinical Nutrition,17, p80.
</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>University of Newcastle Human Research Ethics Committee</ethicname>
      <ethicaddress>Chancellery Building
University Drive
University of Newcastle
Callaghan, NSW 2308</ethicaddress>
      <ethicapprovaldate>30/11/2006</ethicapprovaldate>
      <hrec>H-291-090</hrec>
      <ethicsubmitdate>5/10/2006</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment>
    <filepath>http://www.anzctr.org.au/AnzctrAttachments/81597-Micallef &amp; Garg.JN 2008.pdf</filepath>
    <filepath>http://www.anzctr.org.au/AnzctrAttachments/81597-Micallef &amp; Garg.Atherosclerosis 2009.pdf</filepath>
  </attachment>
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Ms Michelle Micallef</name>
      <address>School of Biomedical Sciences
Nutraceuticals Research Group
The University of Newcastle
Medical Sciences Building 305a
Callaghan Campus
NSW, 2308</address>
      <phone>(02) 4921 5638</phone>
      <fax />
      <email>michelle.micallef@studentmail.newcastle.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Professor Manohar Garg</name>
      <address>School of Biomedical Sciences
Nutraceuticals Research Group
The University of Newcastle
Medical Sciences Building 305c
Callaghan Campus
NSW 2308</address>
      <phone>(02)4921 5647</phone>
      <fax>(02)4921 2028</fax>
      <email>manohar.garg@newcastle.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Manohar Garg</name>
      <address>305C Medical Science Building
University of Newcastle
Callaghan, NSW 2308</address>
      <phone>+61-2-4921 5647</phone>
      <fax />
      <email>manohar.garg@newcastle.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>